HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.

AbstractBACKGROUND:
Pentraxin 3 (PTX3) is an acute phase protein, involved in antibacterial resistance. Recent studies have shown PTX3 levels to be elevated in the presence of a bacterial infection and in a murine sepsis model.
OBJECTIVE:
We aim to investigate if sputum PTX3 can be used as a biomarker for bacterial infection in subjects with COPD.
MATERIALS AND METHODS:
Sputum samples from 142 COPD patients (102 men) with a mean (range) age of 69 years (45-85) and mean (SD) post-bronchodilator percentage predicted forced expiratory volume in 1 second (FEV1) of 50% (19) were analyzed for PTX3, using a commercial assay at stable state and during an exacerbation. Association with bacteria, from culture, quantitative real-time polymerase chain reaction (qPCR) and colony-forming units (CFU) was investigated.
RESULTS:
The geometric mean (95% CI) PTX3 level at stable state was 50.5 ng/mL (41.4-61.7). PTX3 levels correlated with absolute neutrophil count in sputum (r=0.37; P<0.01), but not FEV1 or health status. There was a weak correlation between PTX3 and bacterial load (CFU: r=0.29, P<0.01; 16S qPCR: r=0.18, P=0.05). PTX3 was a poor predictor of bacterial colonization (defined as >105 CFU/mL at stable state) with a receiver-operating characteristic (ROC) area under the curve (AUC) of 0.59 and 95% confidence interval (CI) 0.43-0.76 (P=0.21). During an exacerbation, there was a modest increase in PTX3 (fold difference 0.15, 95% of difference 0.02-0.29; P=0.02), and PTX3 fared better at identifying a bacteria-associated exacerbation (ROC AUC 0.65, 95% CI 0.52-0.78, P=0.03).
CONCLUSION:
PTX3 is associated with bacterial infection in patients with COPD, but its utility as a biomarker for identifying a bacteria-associated exacerbation warrants further studies.
AuthorsSamantha J Thulborn, Madiha Dilpazir, Koirobi Haldar, Vijay Mistry, Christopher E Brightling, Michael R Barer, Mona Bafadhel
JournalInternational journal of chronic obstructive pulmonary disease (Int J Chron Obstruct Pulmon Dis) Vol. 12 Pg. 1199-1205 ( 2017) ISSN: 1178-2005 [Electronic] New Zealand
PMID28458531 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Serum Amyloid P-Component
  • PTX3 protein
  • C-Reactive Protein
Topics
  • Aged
  • Aged, 80 and over
  • Area Under Curve
  • Bacterial Infections (diagnosis, metabolism, microbiology, physiopathology)
  • Bacterial Load
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Forced Expiratory Volume
  • Humans
  • Longitudinal Studies
  • Lung (physiopathology)
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive (diagnosis, metabolism, microbiology, physiopathology)
  • ROC Curve
  • Serum Amyloid P-Component (metabolism)
  • Sputum (metabolism, microbiology)
  • Time Factors
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: